Published in
American Association for the Advancement of Science, Science Translational Medicine, 389(9), 2017
DOI: 10.1126/scitranslmed.aal3920
Links
Tools
Leukotriene B 4 antagonism ameliorates experimental lymphedema
Journal article published in 2017 by
Wen Tian 
,
Stanley G. Rockson ,
Xinguo Jiang ,
Jeanna Kim ,
Adrian Begaye,
Eric M. Shuffle ,
Allen B. Tu ,
Matthew Cribb ,
Zhanna Nepiyushchikh ,
Abdullah H. Feroze ,
Roham T. Zamanian ,
Gundeep S. Dhillon ,
Norbert F. Voelkel,
Marc Peters-Golden,
Jan Kitajewski
and other authors.
,
Stanley G. Rockson ,
Xinguo Jiang ,
Jeanna Kim ,
Adrian Begaye,
Eric M. Shuffle ,
Allen B. Tu ,
Matthew Cribb ,
Zhanna Nepiyushchikh ,
Abdullah H. Feroze ,
Roham T. Zamanian ,
Gundeep S. Dhillon ,
Norbert F. Voelkel,
Marc Peters-Golden,
Jan Kitajewski
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Lymphedema is a common debilitating condition with very limited treatment options, and leukotriene B 4 may be a key pathogenic molecule and therapeutic target.